发明名称 NEUE CEPHALOSPORIN-C-ACYLASE.
摘要 A mutant cephalosporin C acylase ("CC acylase") of the formula (as its precursor before processing the said precursor form into alpha -subunit and beta -subunit thereof in a host cell): A<1><-><2><6><8>-X<1>-Tyr-X<2>-A<2><7><2><-><3><0><4>-X<3>-A<3><0><6>< -><7><7><3 > wherein A<1><-><2><6><8> is the same amino acid sequence as that from Thr<1> to Gly<2><6><8> of native CC acylase, A<2><7><2><-><3><0><4> is the same amino acid sequence as that from Gln<2><7><2> to Tyr<3><0><4> of native CC acylase, A<3><0><6><-><7><7><3> is the same amino acid sequence as that from Val<3><0><6> to Ala<7><7><3> of native CC acylase, X<1> is Met or other amino acid, X<2> is Ala or other amino acid and X<3> is Cys or other amino acid, providing that when X<1> is Met and X<2> is Ala, X<3> is an amino acid other than Cys. A DNA coding for the CC acylase is also provided, together with an expression vector containing the said DNA and a microorganism transformed with the said expression vector. The CC acylase is produced by culturing the said transformed microorganism in an aqueous nutrient medium.
申请公布号 AT121784(T) 申请公布日期 1995.05.15
申请号 AT19930301250T 申请日期 1993.02.19
申请人 FUJISAWA PHARMACEUTICAL CO., LTD. 发明人 NIWA, MINEO;SAITO, YOSHIMASA;SASAKI, HITOSHI;ISHII, YOSHINORI
分类号 C12N1/21;C12N9/80;C12N15/09;C12N15/55;C12P35/02;C12P35/06;C12R1/19 主分类号 C12N1/21
代理机构 代理人
主权项
地址